Semaglutide, the active pharmaceutical ingredient in Wegovy, is a synthetic peptide analogue of human GLP-1 with 94% structural homology to the native hormone
Under medical supervision, it may be considered for patients who report anxiety, trouble concentrating, or cognitive changes that make stress feel more difficult to manage
It is worth mentioning that China's FDA said that the application for a marketing license for LIR injection for obesity or overweight indications had been accepted, which was the first time that the weight control indications of GLP-1R agonists have been accepted in China
As of this writing, neither cagrilintide monotherapy nor the CagriSema combination is approved for any indication anywhere, and it may not be prescribed or sold for human use
Research on these ingredients and their potential weight loss benefits is limited although some small studies exist, says Kristen Lorenz, RD, a dietitian in private practice
Many organs, including the nerves, kidneys, eyes, and blood vessels, can be damaged by uncontrolled diabetes, which results in high blood sugar, or hyperglycemia